GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Faron Pharmaceuticals Oy (FRA:4FR) » Definitions » Cyclically Adjusted PB Ratio

Faron Pharmaceuticals Oy (FRA:4FR) Cyclically Adjusted PB Ratio : 32.77 (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Faron Pharmaceuticals Oy Cyclically Adjusted PB Ratio?

As of today (2024-12-14), Faron Pharmaceuticals Oy's current share price is €1.966. Faron Pharmaceuticals Oy's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was €0.06. Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio for today is 32.77.

The historical rank and industry rank for Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:4FR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 50.1
Current: 37.99

During the past 12 years, Faron Pharmaceuticals Oy's highest Cyclically Adjusted PB Ratio was 50.10. The lowest was 0.00. And the median was 0.00.

FRA:4FR's Cyclically Adjusted PB Ratio is ranked worse than
98.83% of 599 companies
in the Biotechnology industry
Industry Median: 1.58 vs FRA:4FR: 37.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Faron Pharmaceuticals Oy's adjusted book value per share data of for the fiscal year that ended in Dec23 was €-0.183. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.06 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Faron Pharmaceuticals Oy Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faron Pharmaceuticals Oy Cyclically Adjusted PB Ratio Chart

Faron Pharmaceuticals Oy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 35.29 43.20 53.48

Faron Pharmaceuticals Oy Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 43.20 - 53.48 -

Competitive Comparison of Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio falls into.



Faron Pharmaceuticals Oy Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.966/0.06
=32.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faron Pharmaceuticals Oy's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Faron Pharmaceuticals Oy's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.183/121.5400*121.5400
=-0.183

Current CPI (Dec23) = 121.5400.

Faron Pharmaceuticals Oy Annual Data

Book Value per Share CPI Adj_Book
201412 -0.043 100.229 -0.052
201512 0.402 99.990 0.489
201612 0.265 101.020 0.319
201712 0.135 101.510 0.162
201812 0.010 102.710 0.012
201912 0.031 103.650 0.036
202012 -0.033 103.890 -0.039
202112 0.046 107.490 0.052
202212 -0.159 117.320 -0.165
202312 -0.183 121.540 -0.183

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Faron Pharmaceuticals Oy  (FRA:4FR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Faron Pharmaceuticals Oy Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Faron Pharmaceuticals Oy's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Faron Pharmaceuticals Oy Business Description

Traded in Other Exchanges
Address
Joukahaisenkatu 6 B, Turku, FIN, 20520
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested for the prevention of complications that arise from cytokine release syndrome, or hyperinflammatory conditions.

Faron Pharmaceuticals Oy Headlines

No Headlines